Michael Dowd

Michael Dowd currently serves as the VP, Program and Collaboration Lead at Verastem Oncology, a position held since February 2024. Prior to this role, Michael worked as a consultant at Attentum LLC from April 2023 to February 2024, focusing on biopharma project management, alliance management, and trial management. Michael has extensive experience in project and alliance management, having held leadership positions at Molecular Templates and Eli Lilly and Company, among others. Educationally, Michael earned a B.S. in Biomedical Engineering from Boston University between 1982 and 1986.